Curosurf 240mg Injection: Effective Respiratory Support Solution

Curosurf 240mg Injection

Description:

• Contains active components such as Poractant alfa.
• A lung surfactant medication used to treat Respiratory Distress Syndrome (RDS) in premature infants.
• Improves survival and outcomes of premature infants.
• Reduces the risk of death, the need for mechanical ventilation, and the length of hospital stay.
• Suitable for infants at risk of developing bronchopulmonary dysplasia (BPD).
• More stable than other surfactant medications, allowing longer storage without losing effectiveness.

Uses:

• Respiratory distress syndrome (RDS).

Therapeutic Effects:

• Lowers the surface tension in the lungs by forming a film on the surface of the alveoli.
• Reduces the force of attraction between the water molecules in the alveoli, making it easier for them to stay open.

Interaction with Other Drugs:

• Inform the doctor about all medications, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products.
• Certain medications may interact with Curosurf 240mg injection, reducing effectiveness or causing undesirable side effects.

Storage:

• Store at room temperature, between 2°C to 8°C.
• Keep away from moisture, heat, and light.
• Do not freeze.
• Keep away from children and pets.

Administration:

• Administered through a breathing tube into the infant's lungs.
• A relatively simple procedure that can be done in a hospital setting.

Safety Advices:

• Consult a doctor before use if pregnant or planning to become pregnant.
• Safety during breastfeeding is not well established; consult a healthcare provider.
• Individuals with lung or liver conditions should consult a doctor.
• Unsafe to take with alcohol.
• Driving is unsafe after receiving the injection due to potential drowsiness and dizziness.

Side Effects:

• Serious: anaphylaxis, bleeding, pulmonary hemorrhage, intracranial hemorrhage, surfactant protein B deficiency.
• Common: bradycardia, hypotension, hypoxemia, respiratory distress, apnea, froth at the mouth, irritation at the injection site.

Word of Advice:

• Inform your doctor about all medical conditions and medications.
• Be aware of signs and symptoms of an allergic reaction, such as hives, swelling, difficulty breathing, or rash.
• Contact your doctor immediately if you experience any of these symptoms.
• Monitor for signs of problems such as breathing problems, jaundice, or allergic reactions.

FAQs:

1. How long does Curosurf 240mg injection last?

   • The effects typically last for 3 to 5 days. However, some infants may need additional doses.

2. Is Curosurf 240mg injection safe for premature infants?

   • Generally considered safe, but can cause side effects such as bradycardia, hypotension, and hypoxemia.

3. What happens if my infant needs more than one dose of Curosurf 240mg injection?

   • Infants needing more than one dose may be at an increased risk of side effects, but the benefits often outweigh the risks.

4. What are the long-term risks of Curosurf 240mg injection?

   • The long-term risks are not fully known, but there is no evidence of long-term problems.

5. What is the prognosis of Curosurf 240mg injection for infants with RDS?

   • The prognosis has improved significantly. With proper treatment, most infants with RDS make a full recovery.

6. How does Curosurf 240mg injection compare to other synthetic surfactants?

   • Similar effectiveness in treating RDS. Known to cause less bradycardia and hypotension than other synthetic surfactants.

Fact Box:

• Molecule name: Poractant alfa.
• Therapeutic class: Pulmonary surfactants.
• Pharmacological class: Surfactants.
• Indications: Respiratory distress syndrome (RDS), prevention of RDS.

Tags: medical-product, injection, curosurf, pharmaceutical, medicine, healthcare, drug, pulmonary-medicine